A REVIEW OF THE COMBINATION OF XANTHINE AND BRONCHODILATOR DRUG IN MOUTH‑DISSOLVING FILM FOR ASTHMA TREATMENT”
DOI:
https://doi.org/10.22159/ajpcr.2021.v14i11.43091Keywords:
Mouth dissolving oral film, Theo-asthalin, Bronchodilators, Xanthine, AsthmaAbstract
There has been an increase in demand for caregiver dosage forms over the past two decades. In the oral cavity, mouth dissolving film dissolves swiftly. Oral films that dissolve in your mouth function best when combined with medications that act quickly, such as Xanthine category drugs (Salbutamol Sulphate) and Xanthene Derivative Theophylline. According to the World Health Organization (WHO), asthma affects one in six adults and a quarter of all children, according to the WHO. A child’s admission to the hospital is often due to asthma, which is one of the most prevalent reasons for admission. During an asthma attack, quick-relief or rescue drugs are used to relax and open the airways, as well as ease symptoms. If prescribed, these medications can also be administered prior to exercise. To treat asthma, a combination of Salbutamol Sulfate and Theophylline is available in tablet form under the brand name “Theo-Asthalin.” Oral films seem to be the most efficacious formulation. As a consequence, children with asthma should receive support from drugs given in the form of mouth-dissolving films, since they provide better patient compliance and an appropriate treatment method.
Downloads
References
Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm 2013;3:67-76. DOI: https://doi.org/10.4103/2230-973X.114897
Shojaei A. Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci 1998;1:15-30.
Rathbone MJ, Hadgraft J, Roberts MS. Modified Release Drug Delivery Technology. Vol. 1. New York: Marcel Dekkar; 2003. p. 203-4. DOI: https://doi.org/10.1201/9780203910337
Dixit RP, Puthli SP. Oral strip technology: Overview and future potential. J Control Release 2009;139:94-107. DOI: https://doi.org/10.1016/j.jconrel.2009.06.014
Radhakishan UR. Mouth dissolving film and their patent: An overview.Int Res J Pharm 2012;3:39.
Eixarch H. Drug delivery to the lung: Permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS). J Epithelial Biol Pharmacol 2010;3:1-14.
Prasanthi NL. Design and development of sublingual fast dissolving films for an antiasthmatic drug. Pharm Lett 2011;3:382-95.
Shyu WC, Mayol RF, Pfeffer M, Pittman KA, Gammans RE, Barbhaiya RH. Biopharmaceutical evaluation of transnasal, sublingual and buccal disk dosage forms of butorphanol. Biopharm Drug Dispos 1993;14:371 9. DOI: https://doi.org/10.1002/bdd.2510140503
Brakemeier EL, Radtke M, Engel V, Zimmermann J, Tuschen- Caffier B, Hautzinger M, et al. Overcoming treatment resistance in chronic depression: a pilot study on outcome and feasibility of the cognitive behavioral analysis system of psychotherapy as an inpatient treatment program. Psychother Psychosom 2014;84:51-6. DOI: https://doi.org/10.1159/000369586
Patel R, Prajapati S, Raval A. Fast dissolving films (FDFs) as a newer venture in fast dissolving dosage forms. Int J Drug Dev Res 2010;2:232–6.
Rathi V, Senthil V, Kammili L, Hans R. A brief review on oral film technology. Int J Res Ayurvedic Pharmacy 2011;2:1138-47.
Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci 2017;12:487-97. DOI: https://doi.org/10.1016/j.ajps.2017.07.004
Singh R, et al. ???. Chem Res Toxicol 2003;16:198-207. DOI: https://doi.org/10.1021/tx025635l
Hussain MW, Kushwaha P, Rahman MA, Akhtar J. Development and evaluation of fast dissolving film for oro-buccal drug delivery of chlorpromazine. Indian J Pharm Educ Res 2017;51:S539-47. DOI: https://doi.org/10.5530/ijper.51.4s.81
Universidade Federal do Rio Grande do Norte. Freeze-drying of Emulsified Systems: A Review. Vol. 503. Universidade Federal do Rio Grande do Norte; 2016. p. 102-14.
Keerthi ML, Kiran RS, Rao VU, Sannapu A, Dutt AG, Krishna KS, et al. Pharmaceutical mini-tablets, its advantages, formulation possibilities and general evaluation aspects: A review. Int J Pharm Sci Rev Res 2014;28:214-21.
Macedo AS, Castro PM, Roque L, Thomé NG, Reis CP, Pintado ME, et al. Novel and revisited approaches in nanoparticle systems for buccal drug delivery. J Control Release 2020;320:125-41. DOI: https://doi.org/10.1016/j.jconrel.2020.01.006
Dash V, Kesari A. Role of biopharmaceutical classification system in drug development program. J Ceramic Proc Res 2011;5:28-31.
Qadir AK. Formulation and evaluation of fast dissolving films of loratidine for sublingual use. Int Res J Pharm 2012;3:157-61.
El-Egakey MA, Soliva M, Speiser P. Hot extruded dosage forms. Technology and dissolution kinetics of polymeric matrices. Pharm Acta Helv 1971;46:31-52.
McGinity JW, Zhang F, Koleng J, Repka M. Hot-melt extrusion as a pharmaceutical process. Am Pharm Rev 2001;4:25-37.
Jain K, Awasthi S, Kumar P, Somashekariah BV, Phani AR. Formulation and pharmacokinetic studies of rapidly dissolving nanofibers. Middle East J Sci Res 2014;22:1176-80.
Bera A, Mukherjee A. A detailed study of mouth dissolving drug delivery system. Acta Chim Pharm Indica 2013;3:65-93.
Chaudhary H, Gauri S, Rathee P, Kumar V. Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using Box Behnken statistical design. Bull Fac Pharm Cairo Univ 2013;51:193-201. DOI: https://doi.org/10.1016/j.bfopcu.2013.05.002
Mishra DN, Bindal M, Singh SK, Kumar SG. Spray dried excipient base: A novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull (Tokyo) 2006;54:99-102. DOI: https://doi.org/10.1248/cpb.54.99
Mangal-Mohit TN, Bansal R, Thakral S, Goswami M. Fast dissolving tablet: An approach for emergency treatment. Int J Res Ayurveda Pharm 2012;3:377-80.
Dokala GK, Pallavi C. Direct compression-an overview. Intl J Res Pharm Biom Sci 2013;4:155-8.
Shiv G, Ajay P, Prateek P, Sanket T, Deepu P, Pramod S, et al. Formulation and evaluation of fast dissolving tablet of ziprasidone HCL. Am J Pharm Res 2013;3:245-9.
Bhattarai M, Gupta A. Fast dissolving oral films: A novel trend to oral drug delivery system. Sunsari Tech Coll J 2015;2:58-68. DOI: https://doi.org/10.3126/stcj.v2i1.14802
Reddy TU, Sunil K, Reddy K, Manogna KK, Thyagaraju K. A detailed review on fast dissolving oral films. Indo Am J Pharm Res 2018;8:1351 26.
Ghodake SP, Karande KM, Osmani RA, Bhosale RR, Harkare BR, Kale BB. Mouth dissolving films: Innovative vehicle for oral drug delivery. Int J Pharm Res Rev 2013;2:41-7.
Chaurasiya P, Kharel R, Manasa DR, Rajashekhar V, Sridhar KA. A review on oral fast dissolving films a novel drug delivery system. Asian J Res Chem Pharm Sci 2016;4:165-75.
Joshua JM, Hari R, Jyothish FK, Surendra SA. Fast dissolving oral thin films: An effective dosage form for quick releases. Int J Pharm Sci Rev Res 2016;38:282-9.
Padamwar PA. Formulation and evaluation of fast dissolving oral film of bisoprolol fumarate. Int J Pharm Sci Res 2015;6:135-42.
George SJ, Vasudevan DT. Studies on the preparation, characterization, and solubility of 2 HP-β-cyclodextrin-meclizine HCl inclusion complexeses. J Young Pharm 2012;4:220-7. DOI: https://doi.org/10.4103/0975-1483.104365
Ali MS, Vijendar C, Sudheerkumar D, Krishnaveni J. Formulation and evaluation of fast dissolving oral films of Diazepam. J Pharmacovigil 2016;4:1-5. DOI: https://doi.org/10.4172/2329-6887.1000210
Lee J, McDonald C. Review: Immunotherapy improves some symptoms and reduces long-term medication use in mild to moderate asthma. Ann Intern Med 2018;169:JC17. DOI: https://doi.org/10.7326/ACPJC-2018-169-4-017
Tesfaye ZT, Gebreselase NT, Horsa BA. Appropriateness of chronic asthma management and medication adherence in patients visiting ambulatory clinic of Gondar university hospital: A cross-sectional study. World Allergy Organ J 2018;11:18. DOI: https://doi.org/10.1186/s40413-018-0196-1
Piloni D, Tirelli C, Domenica RD, Conio V, Grosso A, Ronzoni V, et al. Asthma-like symptoms: Is it always a pulmonary issue? Multidiscip Respir Med 2018;13:21. DOI: https://doi.org/10.4081/mrm.2018.167
Rajan S, Gogtay NJ, Konwar M, Thatte UM. The global initiative for asthma guidelines (2019): Change in the recommendation for the management of mild asthma based on the SYGMA-2 trial a critical appraisal. Lung India 2020;37:169-73. DOI: https://doi.org/10.4103/lungindia.lungindia_308_19
National Asthma Education and Prevention Program. Guideline for the Diagnosis and Management of Asthma. Expert Panel Report II. Bethesda (Md); NIH, National Heart, Lung, and Blood Institute; 1997. NIH publication No. 97-4051.
Janson C, Chinn S, Jarvis D, Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 1997;10:17951802. DOI: https://doi.org/10.1183/09031936.97.10081795
Magnus P, Jaakkola JK. Secular trend in the occurrence of asthma among children and young adults: Critical appraisal of repeated cross sectional surveys. BMJ 1997;314:17951799. DOI: https://doi.org/10.1136/bmj.314.7097.1795
Weinberg EG. Urbanization and childhood asthma: An African perspective. J Allergy Clin Immunol 2000;105:224-31. Saleh JA, Ind PW. Concurrent therapy (long acting beta agonists and inhaled corticosteroids) in the management of asthma. Nig J Med 2006;15: 63
Published
How to Cite
Issue
Section
Copyright (c) 2021 DEVENDRA SINGH LODHI, AAKASH SINGH PANWAR, PRADEEP GOLANI, MEGHA VERMA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
